The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
SOLTI-1303 PATRICIA: A phase II study of palbociclib and trastuzumab (HR+ with or without letrozole) in trastuzumab‐pretreated, postmenopausal patients with HER2‐positive metastatic breast cancer.
 
Patricia Villagrasa
No Relationships to Disclose
 
Aleix Prat
Consulting or Advisory Role - NanoString Technologies (Inst)
Research Funding - NanoString Technologies (Inst)
 
Mafalda Oliveira
Consulting or Advisory Role - Roche/Genentech
Research Funding - AstraZeneca (Inst); Genentech/Roche (Inst)
 
Lorena De La Pena
No Relationships to Disclose
 
Xavier Gonzalez
No Relationships to Disclose
 
Javier Cortes
Stock and Other Ownership Interests - MedSIR
Honoraria - Celgene; Eisai; Novartis; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; Biothera; Celgene; Cellestia Biotech; Merus; Roche
 
Sonia Pernas Simon
No Relationships to Disclose
 
Jose Rios
No Relationships to Disclose
 
Jordi Canes
No Relationships to Disclose
 
Eva Ciruelos
No Relationships to Disclose